CytomX Therapeutics (CTMX) Earnings Date & Reports

CytomX Therapeutics Inc a clinical-stage, oncology-focused biopharmaceutical company developing novel, masked, conditionally activated biologics designed to be localized to the tumor microenvironment... Show more

Industry: #Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

CTMX is expected to report earnings to fall 21.11% to -7 cents per share on November 10

CytomX Therapeutics CTMX Stock Earnings Reports

Q3'26

Est.

$-0.07

Q2'26

Missed

by $0.01

Q1'26

Beat

by $0.02

Q4'25

Missed

by $0.08

Q3'25

Missed

by $0.04

The last earnings report on August 06 showed earnings per share of -9 cents, missing the estimate of -7 cents. With 2.62M shares outstanding, the current market capitalization sits at 738.68M.

View a ticker or compare two or three

CTMX

Daily Signal:

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

Last 5 trading days